China Universal Asset Management Company’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
HIM
II
IC
China Universal Asset Management Company's IRWD Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Ironwood Pharmaceuticals (IRWD) stake by 9.5% in Q2 2026, selling an estimated $10.6K and leaving 26,198 shares worth $110K. The position accounts for 0.01% of the portfolio, ranked #410.
China Universal Asset Management Company first reported a position in IRWD in Q3 2022 and has held it in 16 quarters since. The position peaked at $262K in Q1 2024. 123 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.
- China Universal Asset Management Company held 26,198 shares of Ironwood Pharmaceuticals worth $110K as of Q2 2026.
- China Universal Asset Management Company sold 2,738 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $10.6K.
- Ironwood Pharmaceuticals made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #410 holding.
- China Universal Asset Management Company first reported a position in Ironwood Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's Ironwood Pharmaceuticals position peaked at $262K in Q1 2024.
- 123 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.